CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis
Namki Hong, Yong-ho Lee, Kenichi Tsujita, Jorge A. Gonzalez, Christopher M. Kramer, Tomas Kovarnik, George N. Kouvelos, Hiromichi Suzuki, Kyungdo Han, Chan Joo Lee, Sung Ha Park, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
Endocrinol Metab. 2018;33(2):219-227.   Published online May 4, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.2.219

Excel Download

Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis
Endocrinology and Metabolism. 2018;33(2):219   Crossref logo
Link1 Link2 Link3

Ezetimibe/statin combination therapy to treat patients with type 2 diabetes
Atherosclerosis Supplements. 2015;17:2-8   Crossref logo
Link1 Link2

Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study
Scientific Reports. 2018;8(1):   Crossref logo
Link1 Link2 Link3

Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials
Diabetes, Obesity and Metabolism. 2011;13(7):615-628   Crossref logo
Link1 Link2

Adverse effects of incretin-based therapies on major cardiovascular and arrhythmia events: meta-analysis of randomized trials
Diabetes/Metabolism Research and Reviews. 2016;32(8):843-857   Crossref logo
Link1 Link2

Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in patients with diabetes and cardiovascular disease or risk: A systematic review and meta-analysis of 13,395 patients
Diabetes and Vascular Disease Research. 2017;14(5):400-406   Crossref logo
Link1 Link2 Link3

Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes
Diabetes and Vascular Disease Research. 2011;8(2):160-172   Crossref logo
Link1 Link2

172: Combination therapy for mixed dyslipidemia and its effects on multiple lipids: Niacin extended release + statin versus ezetimibe + statin
Journal of Clinical Lipidology. 2008;2(5):S79-S80   Crossref logo
Link1 Link2

Bupropion and/or naltrexone are not associated with increased risk of major adverse cardiovascular events: A network meta-analysis of additive effects
Atherosclerosis. 2020;315:e9   Crossref logo
Link1 Link2

Ezetimibe–Statin Combination to Reduce Cardiovascular Events: The Evidence Base
Metabolic Syndrome and Related Disorders. 2015;13(8):327-328   Crossref logo
Link1 Link2